This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

SuperReturn Asia
24 - 27 September 2024
Marina Bay Sands Convention CentreSingapore

Michael Rees
Co-President at Blue Owl Capital
Speaker

Profile

Michael Rees is a Co-President of Blue Owl Capital Inc., a member of the firm’s Executive Committee, and a member of the firm’s board of directors. Michael is also the Head of the GP Strategic Capital platform. Previously, Michael founded Dyal Capital, the predecessor firm to Blue Owl’s GP Strategic Capital (GPSC) platform. GPSC manages over $50bn in minority GP stakes representing nearly $2Trillion of total AUM. Across over 80 transactions, GPSC has formed partnerships with 66 alternative asset management firms.

Prior to founding Dyal Capital, Michael was a founding employee and shareholder of Neuberger Berman Group, transitioning from Lehman Brothers as part of the management buyout transaction in May 2009, and was the first Chief Operating Officer of Neuberger’s alternatives business. Michael was an employee of Lehman Brothers from April 2001 through May 2009. He had numerous roles at Lehman Brothers and was responsible for strategic acquisitions for the Investment Management Division. From 2003 through 2006, he was Head of Asset Management Strategy. Prior to joining Lehman Brothers, Michael was an associate at Marakon Associates.

Michael currently serves on the Board of Directors of The Feinstein Institutes for Medical Research of Northwell Health and on the board of The Opportunity Network, an education-focused nonprofit that supports underserved students with postsecondary career readiness education.

Michael received an MS in Mechanical Engineering and an MS in Technology Policy from Massachusetts Institute of Technology, and a BS in Mechanical Engineering and a BA in Political Science from the University of Pittsburgh.

Agenda Sessions

  • Keynote address

    11:35